Home
Portfolio
Class 12
About Us
Team
iSafe
Investor Hub
arrow-icon
Founders' Hub
arrow-icon
Partners
arrow-icon
News and Views
arrow-icon
Analyst Trainee Program
Contact Us
photo
100X.VC Team
Written by various collaborators within Team 100X.VC
Recent Memos
Inzpira: 100X Investment Thesis
Read more
Why We Invested in AgriGator
Read more
Roopya: 100X.VC Investment Thesis
Read more
DataKund: 100X Investment Thesis
Read more
date-icon
Jan 24, 2023
Topic

Introduction:

It has been surveyed that the pain of kidney stones can be as dreadful & excruciating as a mother delivering a baby. 17 crore Indians are suffering from the problem of kidney stones every year but only a few million are getting their kidney stones operated. The remaining Indians go through this pain day in & day out because of 2 reasons - either they fear surgeries or they don’t have enough money to get it operated. Average cost of surgeries can be somewhere between Rs.30,000 to 2 lakhs & sometimes even more if the stones keep recurring.

The burden of kidney stones in India is further compounded by a lack of access to proper diagnosis and treatment, particularly in rural areas. Dr Mantra aims to address these challenges by providing cost-effective and holistic solutions for those suffering from kidney stones in India, by utilising the proven formulations of Ayurveda along with diet plans & doctor consultations.

The idea of Dr Mantra cropped up due to a serious lack of thought leadership in kidney stone pre-operative solutions. Dr Mantra procures hand-picked proven ayurvedic ingredients which are 100% Natural with no-side effects, which has resulted in a 60% faster treatment with a personalised ayurvedic approach.

Dr Mantra is founded by 2 exceptional founders with a hardcore sales experience. Takki Zain has 6+ years of hardcore sales & business development experience in big shot companies like BYJU’s & Livspace. Shivansh Jain has an experience of  6+ years of sales & digital marketing in highly aggressive startups like BYJU’s & Lybrate. Both of them have bootstrapped Dr Mantra in the midst of COVID-19 pandemic, made it profitable & scaled it up to 20 lakhs monthly revenue with 15% MoM growth.

Market Opportunity:

The market sentiment is shifting from immediate curative measures to wholistic overall wellness. Owing to the sudden boost in the ayurvedic wellness industry post COVID-19, the ayurvedic industry is growing at a CAGR of 19%. Kidney stone ayurvedic wellness is a hugely untapped market of $7.87 billion.

100X Thesis:

Kidney stone is a very common ailment and has millions suffering from the same. This is also Dr Mantra’s hero product currently and they have sales growing in the same segment. Ayurveda is a growing therapy worldwide which supposedly has less side effects. It’s popularity has gained momentum in the last 5-6 years. Dr Mantra’s promising founder team, their xp in this field and a whole range of products to be launched later makes this a promising bet in healthcare space.

Conclusion:

Both the founders are well experienced in the space and are already seeing fantastic traction in the space with stupendous repeat purchases which shows the proof of the concept and finesse in the execution. We feel, combined with the market opportunity and given the founders commitment and passion towards the business, this company can grow leaps & bounds. We think this is an exciting opportunity and believe that the team has a strong product portfolio to give tough competition in the market. 

Related topics
sales-logo
watch-logo.svg3 min
Inzpira: 100X Investment Thesis
Inzpira is an AI enabled, personalized soft skills training, simulator and measuring platform with a...
Read morenext-arrow
james100X.VC Team
May 19, 2021
sales-logo
watch-logo.svg3 Min min
Why We Invested in AgriGator
AgriGator is a digital platform where traders, millers and processors can buy & sell grain commoditi...
Read morenext-arrow
james100X.VC Team
Sep 14, 2020
sales-logo
watch-logo.svg3 min
Roopya: 100X.VC Investment Thesis
Read why 100X invested in Roopya which is India’s First ‘Specified User Fintech’ Powering Lenders wi...
Read morenext-arrow
Tags:
Fintech
james100X.VC Team
Jun 24, 2023
logo-footer
100X.VC is the first Venture Capital firm to invest in early stage startups using founder friendly India SAFE Notes.
Send Your pitches to us at:
www.100x.vc/class12
For other queries, please contact us at:
Portfolio
Class 12
About Us
Team
iSafe
Partners
Investor Hub
Founders Hub
News and Views
Contact Us
© 2000-2021, All Rights Reserved